H1 (Interim)
BDMD — H1 2026 Financial Report Analysis
Baird Medical swung to a $13,499 first-half profit on revenue up 24.6% to $9.9M, but all of the growth came from $4.8M of new overseas licensing fees while device sales fell 37.8% and cash ended at $0.14M.